![Dirk Huebner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Huebner
Hoofd Techniek/Wetenschap/O&O bij
APTEVO THERAPEUTICS INC.
Vermogen: 1 981 $ op 31-07-2026
Profiel
Dirk Huebner is Chief Medical Officer & Senior Vice President at Aptevo Therapeutics, Inc. since 2025.
Formerly, Dr. Huebner was Executive Medical Director at Millennium Pharmaceuticals, Inc. in 2017, Chief Medical Officer at Mersana Therapeutics, Inc. from 2018 to 2020, and Vice President at Boston Biomedical, Inc. from 2017 to 2018.
Education includes a doctorate from Freie Universität Berlin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-08-2026 | 482 ( 0,04% ) | 1 981 $ | 31-07-2026 |
Actieve functies van Dirk Huebner
| Bedrijven | Functie | Begin |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 |
Eerdere bekende functies van Dirk Huebner
| Bedrijven | Functie | Einde |
|---|---|---|
| MERSANA THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 30-11-2020 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Corporate Officer/Principal | 01-11-2018 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01-08-2017 |
Opleiding van Dirk Huebner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
46
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Commercial Services |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
